Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Denali Capital Acquisition Corp Class A ( (DNQAF) ) has issued an update.
On August 20, 2025, Denali Capital Acquisition Corp., a Cayman Islands exempted company, entered into a Securities Purchase Agreement with Semnur Pharmaceuticals, Inc. and a purchaser, to sell 1,250,000 shares of common stock at $16.00 per share, totaling $20,000,000. This agreement is part of a Business Combination with Semnur, which includes a merger plan and the establishment of an escrow account for 12,000,000 shares of New Semnur common stock. The transaction is expected to close following the Business Combination, with the agreement containing standard representations and conditions.
More about Denali Capital Acquisition Corp Class A
Average Trading Volume: 609
Technical Sentiment Signal: Hold
Current Market Cap: $30.19M
For detailed information about DNQAF stock, go to TipRanks’ Stock Analysis page.